speb/financial-data huggingface dataset:
Financial ratios for DMGI.V — quarterly report dated 2024-12-31
Total revenue: 8134842.657342657
Gross profit: 7610687.412587413
Operating income: -1613713.9860139862
Net income: -2169930.7692307695
Capital expenditures: 6921722.377622378
Operating cash flow: -1910062.937062937
Depreciation & amortization: 3041588.8111888114
Net tangible assets: 79017194.40559441
Owner earnings: -6050064.335664336
Return on net tangible assets (%): -7.6566428119548515
Buffett classification: The Gruesome
Stock price: 0.2377622377622378
Shares outstanding: 206901497
Book value: 79210229.37062939
P/B ratio: 0.6210481059573537
Market cap (USD): 49193362.92307693
Debt to equity: 0.17746988213043188
Current ratio: 2.9096934426365797
Quick ratio: 2.9096934426365797
Interest coverage ratio: -4.954208781677502
COGS to revenue (%): 6.443335991042589
R&D to revenue (%): 4.762076279837443
SG&A to revenue (%): 13.239810622097384
Free cash flow (dilution-adjusted): -9499315.384615386
Buyback yield (%): 0
Retained earnings: -61418939.16083916
Receivables turnover: 2.422019702915545
Capitalized R&D asset: 387387.41258741263
ROCI (R&D-adjusted, %): -1.7022636448232782
FCF margin (%): -116.77319137870639
Rule of 40 score: -116.77319137870639
Financial ratios for DMGI.V — quarterly report dated 2025-03-31
Total revenue: 8842359.440559441
Gross profit: 8284288.811188811
Operating income: -2053971.3286713287
Net income: -2340105.5944055943
Capital expenditures: 1537110.4895104896
Operating cash flow: -688124.4755244756
Depreciation & amortization: 3016858.7412587414
Net tangible assets: 72415235.66433567
Owner earnings: -860357.3426573426
Return on net tangible assets (%): -1.1880888528007187
Buffett classification: The Gruesome
Stock price: 0.15384615384615385
Shares outstanding: 206901497
Book value: 72608270.62937063
P/B ratio: 0.43839357779147603
Market cap (USD): 31830999.53846154
Debt to equity: 0.19890434759175707
Current ratio: 2.606693296380922
Quick ratio: 2.606693296380922
Interest coverage ratio: -9.533169317853561
COGS to revenue (%): 6.311339551652749
R&D to revenue (%): 4.8119296071184365
SG&A to revenue (%): 14.362176218827141
Free cash flow (dilution-adjusted): -2740699.3006993006
Buyback yield (%): 0
Retained earnings: -63759044.75524476
Receivables turnover: 3.25157466890423
Capitalized R&D asset: 685037.6783216784
ROCI (R&D-adjusted, %): -2.588326856760705
Rosenberg metric: 1.7388314042067718
FCF margin (%): -30.995113002620727
Revenue growth (%): 8.697362850382437
Rule of 40 score: -22.29775015223829
Financial ratios for DMGI.V — quarterly report dated 2025-06-30
Total revenue: 8477890.510948904
Gross profit: 7777652.554744525
Operating income: -1743538.6861313868
Net income: -278214.59854014596
Capital expenditures: 5574309.489051094
Operating cash flow: 13145983.941605838
Depreciation & amortization: 3272674.452554744
Net tangible assets: 83219756.20437956
Owner earnings: -2579849.635036496
Return on net tangible assets (%): -3.1000446921529528
Buffett classification: The Gruesome
Stock price: 0.1751824817518248
Shares outstanding: 206901497
Book value: 83421245.25547445
P/B ratio: 0.43448785272417345
Market cap (USD): 36245517.72262774
Debt to equity: 0.11298840658367881
Current ratio: 3.4816570731002097
Quick ratio: 3.4816570731002097
Interest coverage ratio: -7.35647674776717
COGS to revenue (%): 8.25958633491495
R&D to revenue (%): 4.195619176027641
SG&A to revenue (%): 14.392912091649299
Free cash flow (dilution-adjusted): 7034783.941605839
Buyback yield (%): 0
Retained earnings: -66829626.277372256
Receivables turnover: 2.9320568785272654
Capitalized R&D asset: 768614.8811188812
ROCI (R&D-adjusted, %): -2.1091743074893436
Rosenberg metric: -1.1907177716342723
FCF margin (%): 82.97799945069659
Revenue growth (%): -4.121851549471484
Rule of 40 score: 78.8561479012251
Financial ratios for DMGI.V — annual report dated 2025-09-30
Total revenue: 34055446.04316547
Gross profit: 31735693.52517986
Operating income: -6700401.438848921
Net income: -7387028.057553957
Capital expenditures: 13995495.683453238
Operating cash flow: 11647360.431654677
Depreciation & amortization: 12516880.575539568
Net tangible assets: 81588313.66906476
Owner earnings: -8865643.165467627
Return on net tangible assets (%): -10.866314998773099
Buffett classification: The Gruesome
Stock price: 0.34532374100719426
Shares outstanding: 206901497
Book value: 82438251.79856116
P/B ratio: 0.8666850328002201
Market cap (USD): 71447998.96402878
Debt to equity: 0.09660851021086897
Current ratio: 4.038769727078616
Quick ratio: 4.038769727078616
Interest coverage ratio: -7.246016019170099
COGS to revenue (%): 6.811693245906433
R&D to revenue (%): 4.87884231111051
SG&A to revenue (%): 11.821678021052001
Free cash flow (dilution-adjusted): -5269220.863309353
Buyback yield (%): 0
Retained earnings: -68341043.88489209
Receivables turnover: 11.702147331095102
Capitalized R&D asset: 3193897.7033839594
ROCI (R&D-adjusted, %): -7.701941290229166
Rosenberg metric: 5.919228857868318
FCF margin (%): -15.47247643337452
Revenue growth (%): 35.61870086947394
Rule of 40 score: 20.14622443609942
Financial ratios for DMGI.V — quarterly report dated 2025-09-30
Total revenue: 8233784.892086332
Gross profit: 7717564.028776979
Operating income: -1213553.9568345326
Net income: -2472994.964028777
Capital expenditures: 200860.43165467627
Operating cash flow: 1363482.7338129496
Depreciation & amortization: 3058505.0359712234
Net tangible assets: 81588313.66906476
Owner earnings: 384649.64028777
Buffett classification: The Gruesome
Stock price: 0.34532374100719426
Shares outstanding: 206901497
Book value: 82438251.79856116
P/B ratio: 0.8666850328002201
Market cap (USD): 71447998.96402878
Debt to equity: 0.09660851021086897
Current ratio: 4.038769727078616
Quick ratio: 4.038769727078616
Interest coverage ratio: -9.03280391547878
COGS to revenue (%): 6.2695451736358025
R&D to revenue (%): 5.764807761249688
SG&A to revenue (%): 4.964123512522236
Free cash flow (dilution-adjusted): 389460.43165467633
Buyback yield (%): 0
Retained earnings: -68341043.88489209
Receivables turnover: 2.829296782006946
Capitalized R&D asset: 853391.9474266742
ROCI (R&D-adjusted, %): -1.3887665435417162
Rosenberg metric: -0.16893035132849538
FCF margin (%): 4.730029224214919
Revenue growth (%): -2.8793202571714995
Rule of 40 score: 1.8507089670434191
Financial ratios for DMGI.V — quarterly report dated 2025-12-31
Total revenue: 8156313.138686131
Gross profit: 7494406.569343065
Operating income: -1647616.7883211677
Net income: -1598840.1459854012
Capital expenditures: 318068.6131386861
Operating cash flow: -4101059.1240875907
Depreciation & amortization: 2537488.321167883
Net tangible assets: 71055475.91240875
Owner earnings: 620579.5620437956
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 206901497
Book value: 71917821.8978102
P/B ratio: 0.4829858149329726
Market cap (USD): 34735287.81751825
Debt to equity: 0.16596621188157418
Current ratio: 2.6881908153404592
Quick ratio: 2.6881908153404592
Interest coverage ratio: -6.550323709587085
COGS to revenue (%): 8.115266764386263
R&D to revenue (%): 5.271291800386767
SG&A to revenue (%): 15.141448355485506
Free cash flow (dilution-adjusted): -4846980.2919708025
Buyback yield (%): 0
Retained earnings: -70937563.50364962
Receivables turnover: 2.886543858013075
Capitalized R&D asset: 865347.5189308408
ROCI (R&D-adjusted, %): -2.2487857315175384
Rosenberg metric: -0.47013984754484933
FCF margin (%): -59.426118266366416
Revenue growth (%): -0.9409008665584737
Rule of 40 score: -60.36701913292489
Financial ratios for DRTS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.82
Shares outstanding: 90325876
Market cap (USD): 887000102.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRTS — annual report dated 2022-12-31
Total revenue: 0
Operating income: -9129545.454545455
Net income: -9591477.272727273
Capital expenditures: 256818.18181818182
Operating cash flow: -6783806.818181818
Depreciation & amortization: 278125
Net tangible assets: 30016193.181818184
Owner earnings: -9570170.454545455
Return on net tangible assets (%): -31.88335841449218
Buffett classification: The Gruesome
Stock price: 3.18
Shares outstanding: 90325876
Book value: 30016193.18181818
P/B ratio: 9.569377566972374
Market cap (USD): 287236285.68
Debt to equity: 0.0491496067463585
Current ratio: 24.545182111572153
Quick ratio: 24.545182111572153
Free cash flow (dilution-adjusted): -8957670.454545455
Buyback yield (%): 0
Retained earnings: -24602840.90909091
Receivables turnover: 0
Capitalized R&D asset: 5934659.090909091
ROCI (R&D-adjusted, %): -13.32055605542998
Rule of 40 score: 0
Financial ratios for DRTS — annual report dated 2023-12-31
Total revenue: 0
Operating income: -9856353.591160221
Net income: -8054419.889502762
Capital expenditures: 1768232.0441988949
Operating cash flow: -4960773.480662983
Depreciation & amortization: 296685.0828729282
Net tangible assets: 23335635.35911602
Owner earnings: -9525966.85082873
Return on net tangible assets (%): -40.821544835750224
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 90325876
Book value: 23335635.359116025
P/B ratio: 11.65088854775022
Market cap (USD): 271880886.76
Debt to equity: 0.15715892275821247
Current ratio: 12.074908476485497
Quick ratio: 12.074908476485497
Interest coverage ratio: -475.7333333333333
Free cash flow (dilution-adjusted): -8918508.287292818
Buyback yield (%): 0
Retained earnings: -31977624.309392266
Receivables turnover: 0
Capitalized R&D asset: 11275669.104721246
ROCI (R&D-adjusted, %): -17.877005059143297
Rule of 40 score: 0
Financial ratios for DRTS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.38
Shares outstanding: 90325876
Market cap (USD): 214975584.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRTS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.1
Shares outstanding: 90325876
Market cap (USD): 280010215.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRTS — annual report dated 2024-12-31
Total revenue: 0
Operating income: -9874520.547945205
Net income: -8698630.136986302
Capital expenditures: 613150.6849315069
Operating cash flow: -5420000
Depreciation & amortization: 301917.8082191781
Net tangible assets: 17168767.12328767
Owner earnings: -9009863.013698632
Return on net tangible assets (%): -52.47821785338144
Buffett classification: The Gruesome
Stock price: 3.1
Shares outstanding: 90325876
Book value: 17168767.123287674
P/B ratio: 16.309279145629205
Market cap (USD): 280010215.6
Debt to equity: 0.20004468132639705
Current ratio: 7.40391930835735
Quick ratio: 7.40391930835735
Interest coverage ratio: -118.95049504950494
Free cash flow (dilution-adjusted): -8749863.01369863
Buyback yield (%): 0
Retained earnings: -40413424.65753425
Receivables turnover: 0
Capitalized R&D asset: 14251807.060281541
ROCI (R&D-adjusted, %): -26.345553620743047
Rule of 40 score: 0
Financial ratios for DRTS — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2522493.224932249
Net income: -2355284.5528455283
Capital expenditures: 0
Net tangible assets: 15264227.642276423
Owner earnings: -2355284.5528455283
Return on net tangible assets (%): -15.430093209054593
Buffett classification: The Gruesome
Stock price: 2.51
Shares outstanding: 90325876
Book value: 15264227.642276421
P/B ratio: 14.852893580548603
Market cap (USD): 226717948.76
Debt to equity: 0.21825122059476257
Current ratio: 5.81466311693631
Quick ratio: 5.81466311693631
Buyback yield (%): 0
Retained earnings: -42330623.30623306
Receivables turnover: 0
Capitalized R&D asset: 1943089.430894309
ROCI (R&D-adjusted, %): -5.780523923811469
Rule of 40 score: 0
Financial ratios for DRTS — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -2846017.699115044
Net income: -2983480.825958702
Capital expenditures: 0
Net tangible assets: 25552507.374631267
Owner earnings: -2983480.825958702
Return on net tangible assets (%): -11.675882848666058
Buffett classification: The Gruesome
Stock price: 3.12
Shares outstanding: 90325876
Book value: 25552507.374631267
P/B ratio: 11.028926789383885
Market cap (USD): 281816733.12
Debt to equity: 0.15370051833808573
Current ratio: 10.517165277096618
Quick ratio: 10.517165277096618
Buyback yield (%): 0
Retained earnings: -49060176.99115044
Receivables turnover: 0
Capitalized R&D asset: 3370306.4968702784
ROCI (R&D-adjusted, %): -6.276321854601968
Rule of 40 score: 0
Financial ratios for DRTS — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -3241691.8429003023
Net income: -3530513.595166163
Capital expenditures: 0
Net tangible assets: 23439274.9244713
Owner earnings: -3530513.595166163
Return on net tangible assets (%): -15.06238399670035
Buffett classification: The Gruesome
Stock price: 4.51
Shares outstanding: 90325876
Book value: 23439274.9244713
P/B ratio: 17.37979105892452
Market cap (USD): 407369700.76
Debt to equity: 0.17403072798515157
Current ratio: 8.432680739363448
Quick ratio: 8.432680739363448
Buyback yield (%): 0
Retained earnings: -53776435.04531722
Receivables turnover: 0
Capitalized R&D asset: 4536739.693285765
ROCI (R&D-adjusted, %): -8.69879569960908
Rule of 40 score: 0
Financial ratios for DRTS — annual report dated 2025-12-31
Total revenue: 0
Operating income: -13298113.20754717
Net income: -13404716.981132075
Capital expenditures: 1910377.358490566
Operating cash flow: -8390251.572327044
Depreciation & amortization: 387421.38364779874
Net tangible assets: 24244968.55345912
Owner earnings: -14927672.955974841
Return on net tangible assets (%): -61.570188977807746
Buffett classification: The Gruesome
Stock price: 4.95
Shares outstanding: 90325876
Book value: 24244968.55345912
P/B ratio: 18.44147932030247
Market cap (USD): 447113086.2
Debt to equity: 0.17803084346100467
Current ratio: 7.451984391358143
Quick ratio: 7.451984391358143
Interest coverage ratio: -121.86743515850145
Free cash flow (dilution-adjusted): -13639308.176100628
Buyback yield (%): 0
Retained earnings: -59791194.96855345
Receivables turnover: 0
Capitalized R&D asset: 17451986.6293297
ROCI (R&D-adjusted, %): -24.226693015461137
Rule of 40 score: 0
Financial ratios for DRTS — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -3962893.0817610063
Net income: -3816352.201257861
Capital expenditures: 0
Net tangible assets: 24244968.55345912
Owner earnings: -3816352.201257861
Return on net tangible assets (%): -15.740800788596479
Buffett classification: The Gruesome
Stock price: 4.95
Shares outstanding: 90325876
Book value: 24244968.55345912
P/B ratio: 18.44147932030247
Market cap (USD): 447113086.2
Debt to equity: 0.17803084346100467
Current ratio: 7.451984391358143
Quick ratio: 7.451984391358143
Buyback yield (%): 0
Retained earnings: -59791194.96855345
Receivables turnover: 0
Capitalized R&D asset: 5375382.166903169
ROCI (R&D-adjusted, %): -9.863611213226804
Rule of 40 score: 0
Financial ratios for DXPE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.67
Shares outstanding: 15505312
Market cap (USD): 398021359.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXPE — annual report dated 2022-12-31
Total revenue: 1480832000
Gross profit: 422038000
Operating income: 97752000
Net income: 48155000
Capital expenditures: 4916000
Operating cash flow: 5894000
Depreciation & amortization: 28500000
Net tangible assets: -47952000
Owner earnings: 71739000
Return on net tangible assets (%): -149.60585585585585
Capex to operating income (%): 5.0290531140027825
Buffett classification: The Great
Stock price: 27.55
P/E ratio: 8.870757877686637
Shares outstanding: 15505312
Book value: 365392000
P/B ratio: 1.1690768971406051
Market cap (USD): 427171345.6
Debt to equity: 1.2913419013005212
Current ratio: 2.42419716206124
Quick ratio: 1.9479570316719979
Effective tax rate (%): 27.008694860472527
Interest coverage ratio: 3.355139866140381
COGS to revenue (%): 71.49994057394761
SG&A to revenue (%): 21.898905480162504
Free cash flow (dilution-adjusted): -872000
Buyback yield (%): 11.206744200681236
Retained earnings: 250549000
Inventory turnover: 10.44257929619694
Receivables turnover: 4.2988956884238885
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.857652851419068
FCF margin (%): -0.05888581554153341
Rule of 40 score: -0.05888581554153341
Financial ratios for DXPE — annual report dated 2023-12-31
Total revenue: 1678600000
Gross profit: 505291000
Operating income: 138722000
Net income: 68812000
Capital expenditures: 12263000
Operating cash flow: 106222000
Depreciation & amortization: 30105000
Net tangible assets: -27007000
Owner earnings: 86654000
Return on net tangible assets (%): -320.8575554485874
Capex to operating income (%): 8.839982122518418
Buffett classification: The Great
Stock price: 33.7
P/E ratio: 7.5935740045340925
Shares outstanding: 15505312
Book value: 380879000
P/B ratio: 1.371902925601044
Market cap (USD): 522529014.40000004
Debt to equity: 1.5122151654462441
Current ratio: 2.8931992059420515
Quick ratio: 2.4301251310418666
Effective tax rate (%): 20.84296741093511
Interest coverage ratio: 2.610205848041245
COGS to revenue (%): 69.89806982008817
SG&A to revenue (%): 21.837781484570478
Free cash flow (dilution-adjusted): 90887000
Buyback yield (%): 10.758254269296323
Retained earnings: 319271000
Inventory turnover: 11.303010452290351
Receivables turnover: 4.748595449993494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.55221023192775
FCF margin (%): 5.414452519957107
Revenue growth (%): 13.35519491745181
Rule of 40 score: 18.769647437408917
Financial ratios for DXPE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 53.36
Shares outstanding: 15505312
Market cap (USD): 827363448.3199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXPE — annual report dated 2024-12-31
Total revenue: 1802040000
Gross profit: 556277000
Operating income: 145382000
Net income: 70489000
Capital expenditures: 25068000
Operating cash flow: 102211000
Depreciation & amortization: 33405000
Net tangible assets: -115234000
Owner earnings: 78826000
Return on net tangible assets (%): -68.40515819983686
Capex to operating income (%): 17.24284987137335
Buffett classification: The Great
Stock price: 82.62
P/E ratio: 18.173741682248295
Shares outstanding: 15505312
Book value: 422788000
P/B ratio: 3.0300029268569593
Market cap (USD): 1281048877.44
Debt to equity: 1.5997592173855455
Current ratio: 2.712776247622795
Quick ratio: 2.2901542724113058
Effective tax rate (%): 17.044438167867064
Interest coverage ratio: 2.2741877453970933
COGS to revenue (%): 69.13070742047901
SG&A to revenue (%): 22.801658120796432
Free cash flow (dilution-adjusted): 72429000
Buyback yield (%): 2.2643164137473426
Retained earnings: 389670000
Inventory turnover: 12.081531911592137
Receivables turnover: 4.6194309151499615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.15067254027553
FCF margin (%): 4.019278151428382
Revenue growth (%): 7.353747170260931
Rule of 40 score: 11.373025321689312
Financial ratios for DXPE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82.62
Shares outstanding: 15505312
Market cap (USD): 1281048877.44
Buyback yield (%): 0.017485671619933283
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DXPE — quarterly report dated 2025-03-31
Total revenue: 476569000
Gross profit: 150265000
Operating income: 40515000
Net income: 20589000
Capital expenditures: 17215000
Operating cash flow: 2973000
Depreciation & amortization: 9134000
Net tangible assets: -98912000
Owner earnings: 12508000
Return on net tangible assets (%): -12.645583953413134
Capex to operating income (%): 42.49043564112057
Buffett classification: The Good
Stock price: 82.26
P/E ratio: 15.487237907620576
Shares outstanding: 15505312
Book value: 444659000
P/B ratio: 2.8684159437231678
Market cap (USD): 1275466965.1200001
Debt to equity: 1.548798067732802
Current ratio: 2.696455420773622
Quick ratio: 2.248743974541291
Effective tax rate (%): 24.229934125786627
Interest coverage ratio: 2.7636425648021827
COGS to revenue (%): 68.46941366307921
SG&A to revenue (%): 23.029194093614986
Free cash flow (dilution-adjusted): -18258000
Buyback yield (%): 0
Retained earnings: 410236000
Inventory turnover: 2.969747715606684
Receivables turnover: 1.174949705134021
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5630268359283965
FCF margin (%): -3.8311346310817536
Rule of 40 score: -3.8311346310817536
Financial ratios for DXPE — quarterly report dated 2025-06-30
Total revenue: 498682000
Gross profit: 157813000
Operating income: 45986000
Net income: 23612000
Capital expenditures: 10330000
Operating cash flow: 18646000
Depreciation & amortization: 9490000
Net tangible assets: -71691000
Owner earnings: 22772000
Return on net tangible assets (%): -31.764098701371164
Capex to operating income (%): 22.463358413430175
Buffett classification: The Great
Stock price: 87.65
P/E ratio: 30.746829184860072
Shares outstanding: 15505312
Book value: 468092000
P/B ratio: 2.9033621527392053
Market cap (USD): 1359040596.8000002
Debt to equity: 1.472588721875187
Current ratio: 2.7853484837990785
Quick ratio: 2.334101992674649
Effective tax rate (%): 25.269021395113306
Interest coverage ratio: 3.1189636462289747
COGS to revenue (%): 68.35398109416421
SG&A to revenue (%): 22.42451101102506
Free cash flow (dilution-adjusted): 6817000
Buyback yield (%): 0
Retained earnings: 433826000
Inventory turnover: 3.077601617941819
Receivables turnover: 1.191158310104072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9407170003727683
FCF margin (%): 1.3670034210178028
Revenue growth (%): 4.640041630907592
Rule of 40 score: 6.007045051925395
Financial ratios for DXPE — quarterly report dated 2025-09-30
Total revenue: 513724000
Gross profit: 161259000
Operating income: 43698000
Net income: 21631000
Capital expenditures: 6740000
Operating cash flow: 34886000
Depreciation & amortization: 9920000
Net tangible assets: -53790000
Owner earnings: 24811000
Return on net tangible assets (%): -46.12567391708496
Capex to operating income (%): 15.424046867133507
Buffett classification: The Great
Stock price: 119.07
P/E ratio: 28.04437811155669
Shares outstanding: 15505312
Book value: 488339000
P/B ratio: 3.7806062998040293
Market cap (USD): 1846217499.84
Debt to equity: 1.4082205189427837
Current ratio: 2.7714878301714148
Quick ratio: 2.355704416519246
Effective tax rate (%): 26.5550726606003
Interest coverage ratio: 2.933933127433866
COGS to revenue (%): 68.60979825743006
SG&A to revenue (%): 22.88407783167615
Free cash flow (dilution-adjusted): 26668000
Buyback yield (%): 0.10827543342933543
Retained earnings: 455434000
Inventory turnover: 3.2319930310393836
Receivables turnover: 1.1755052354104123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.696435187613246
FCF margin (%): 5.1911142948353595
Revenue growth (%): 3.016351101503563
Rule of 40 score: 8.207465396338922
Financial ratios for DXPE — annual report dated 2025-12-31
Total revenue: 2016365000
Gross profit: 635928000
Operating income: 176870000
Net income: 88677000
Capital expenditures: 37571000
Operating cash flow: 94264000
Depreciation & amortization: 38850000
Net tangible assets: -77473000
Owner earnings: 89956000
Return on net tangible assets (%): -116.11271023453331
Capex to operating income (%): 21.242155255272234
Buffett classification: The Great
Stock price: 109.79
P/E ratio: 19.19695303720243
Shares outstanding: 15505312
Book value: 498439000
P/B ratio: 3.41531903498723
Market cap (USD): 1702328204.48
Debt to equity: 1.8128657669243378
Current ratio: 3.3408457837427195
Quick ratio: 2.9439593953339864
Effective tax rate (%): 25.620271426414586
Interest coverage ratio: 2.9220221377829176
COGS to revenue (%): 68.46166244702721
SG&A to revenue (%): 22.766612195708614
Free cash flow (dilution-adjusted): 48270000
Buyback yield (%): 1.0050353366039766
Retained earnings: 478257000
Inventory turnover: 12.764804334960793
Receivables turnover: 4.46733960036069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.520227596742064
FCF margin (%): 2.3939118165609896
Revenue growth (%): 11.893465183902688
Rule of 40 score: 14.287377000463678
Financial ratios for DXPE — quarterly report dated 2025-12-31
Total revenue: 527390000
Gross profit: 166591000
Operating income: 46671000
Net income: 22845000
Capital expenditures: 3286000
Operating cash flow: 37759000
Depreciation & amortization: 10306000
Net tangible assets: -77473000
Owner earnings: 29865000
Return on net tangible assets (%): -38.54891381513559
Capex to operating income (%): 7.040774785198517
Buffett classification: The Great
Stock price: 109.79
P/E ratio: 19.19695303720243
Shares outstanding: 15505312
Book value: 498439000
P/B ratio: 3.41531903498723
Market cap (USD): 1702328204.48
Debt to equity: 1.8128657669243378
Current ratio: 3.3408457837427195
Quick ratio: 2.9439593953339864
Effective tax rate (%): 26.30882874745976
Interest coverage ratio: 2.875246426811237
COGS to revenue (%): 68.41218073911148
SG&A to revenue (%): 22.738390944083125
Free cash flow (dilution-adjusted): 33043000
Buyback yield (%): 0.8876079219174755
Retained earnings: 478257000
Inventory turnover: 3.336283104009469
Receivables turnover: 1.1684542391056303
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.303734619593764
FCF margin (%): 6.265382354614232
Revenue growth (%): 2.6601832890812966
Rule of 40 score: 8.925565643695528
Financial ratios for ER7.DE — annual report dated 2021-12-31
Capital expenditures: 2272727.272727273
Depreciation & amortization: 161363636.36363637
Buffett classification: The Gruesome
Stock price: 72.23863636363636
Shares outstanding: 28661415
Market cap (USD): 2070461535.8522725
Quick ratio: 0
Buyback yield (%): 0.4390764538963997
Capitalized R&D asset: 23863636.363636363
Rule of 40 score: 0
Financial ratios for ER7.DE — annual report dated 2022-12-31
Total revenue: 5427659574.468085
Gross profit: 3548936170.212766
Operating income: 1344680851.06383
Net income: 823404255.319149
Capital expenditures: 618085106.3829788
Operating cash flow: 1054255319.1489363
Depreciation & amortization: 520212765.9574468
Net tangible assets: 1495744680.851064
Owner earnings: 725531914.893617
Return on net tangible assets (%): 48.506401137980085
Capex to operating income (%): 45.96518987341772
Buffett classification: The Good
Stock price: 83.97872340425532
P/E ratio: 2.9231680879844957
Shares outstanding: 28661415
Book value: 2388297872.3404255
P/B ratio: 1.0078093987082406
Market cap (USD): 2406949042.6595745
Debt to equity: 0.8926503340757239
Current ratio: 1.5820421136273342
Quick ratio: 1.2943980929678187
Effective tax rate (%): 22.110552763819097
Interest coverage ratio: 11.596330275229358
COGS to revenue (%): 34.61387691101529
R&D to revenue (%): 0.333202665621325
Free cash flow (dilution-adjusted): 428723404.2553192
Buyback yield (%): 0.30938787563237724
Inventory turnover: 2.4392265193370166
Receivables turnover: 13.826558265582657
Capitalized R&D asset: 34073742.74661509
ROCI (R&D-adjusted, %): 27.125547879516777
FCF margin (%): 7.898863190905528
Rule of 40 score: 7.898863190905528
Financial ratios for ER7.DE — annual report dated 2023-12-31
Total revenue: 3612222222.2222223
Gross profit: 2122222222.222222
Operating income: 43333333.333333336
Net income: 121111111.1111111
Capital expenditures: 1015555555.5555556
Operating cash flow: 191111111.1111111
Depreciation & amortization: 360000000
Net tangible assets: 1411111111.1111112
Owner earnings: -534444444.4444445
Return on net tangible assets (%): -37.874015748031496
Capex to operating income (%): 2343.5897435897436
Buffett classification: The Gruesome
Stock price: 76.95555555555556
P/E ratio: 18.21183121926606
Shares outstanding: 28661415
Book value: 2215555555.5555553
P/B ratio: 0.995531395636911
Market cap (USD): 2205655114.3333335
Debt to equity: 1.116850551654965
Current ratio: 1.6973158195316962
Quick ratio: 1.3438035408338094
Effective tax rate (%): 83.80952380952381
Interest coverage ratio: 0.26
COGS to revenue (%): 41.24884650876653
R&D to revenue (%): 1.353429713934174
Free cash flow (dilution-adjusted): -831111111.111111
Buyback yield (%): 0.5037555980037921
Inventory turnover: 2.1663974151857834
Receivables turnover: 14.710407239819006
Capitalized R&D asset: 68880910.16548464
ROCI (R&D-adjusted, %): 1.215365114081263
Rosenberg metric: -78.8888888888889
FCF margin (%): -23.008305136880956
Revenue growth (%): -33.44788536086066
Rule of 40 score: -56.456190497741616
Financial ratios for ER7.DE — annual report dated 2024-12-31
Total revenue: 3055208333.3333335
Gross profit: 1785416666.6666667
Operating income: 72916666.66666667
Net income: 14583333.333333334
Capital expenditures: 623958333.3333334
Operating cash flow: -130208333.33333334
Depreciation & amortization: 157291666.6666667
Net tangible assets: 1147916666.6666667
Owner earnings: -452083333.3333334
Return on net tangible assets (%): -39.382940108892925
Capex to operating income (%): 855.7142857142857
Buffett classification: The Gruesome
Stock price: 54.270833333333336
P/E ratio: 106.66140867857143
Shares outstanding: 28661415
Book value: 2228125000
P/B ratio: 0.698111136746143
Market cap (USD): 1555478876.5625
Debt to equity: 1.03973819541842
Current ratio: 1.6397008837525493
Quick ratio: 1.169272603670972
Effective tax rate (%): 229.2682926829268
Interest coverage ratio: 0.40229885057471265
COGS to revenue (%): 41.56154108421411
R&D to revenue (%): 0.7500852369587453
Free cash flow (dilution-adjusted): -757291666.6666667
Buyback yield (%): 0.334837933951465
Inventory turnover: 1.7615606936416186
Receivables turnover: 13.516129032258064
Capitalized R&D asset: 61640307.328605205
ROCI (R&D-adjusted, %): 1.2516389871040512
Rosenberg metric: -6.889204545454541
FCF margin (%): -24.786907603136722
Revenue growth (%): -15.420255306059671
Rule of 40 score: -40.20716290919639
Financial ratios for ER7.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1147916666.6666667
Buffett classification: The Gruesome
Stock price: 54.270833333333336
Shares outstanding: 28661415
Book value: 2228125000
P/B ratio: 0.698111136746143
Market cap (USD): 1555478876.5625
Debt to equity: 1.03973819541842
Current ratio: 1.6397008837525493
Quick ratio: 1.169272603670972
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ER7.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 635294117.6470588
Buffett classification: The Gruesome
Stock price: 55.34117647058824
Shares outstanding: 28661415
Book value: 2070588235.294118
P/B ratio: 0.7660414554545453
Market cap (USD): 1586156425.4117649
Debt to equity: 1.4034090909090906
Current ratio: 1.5381294964028775
Quick ratio: 1.0589928057553957
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENK — annual report dated 2023-12-31
Total revenue: 181007000
Gross profit: 28292000
Operating income: 11770000
Net income: 11434000
Capital expenditures: 17157000
Operating cash flow: 22164000
Depreciation & amortization: 9534000
Net tangible assets: 7434000
Owner earnings: 3811000
Return on net tangible assets (%): 51.26446058649449
Capex to operating income (%): 145.76890399320305
Buffett classification: The Gruesome
Stock price: 7.77
P/E ratio: 3.6456671471051245
Shares outstanding: 5364808
Book value: 0
Market cap (USD): 41684558.16
Current ratio: 1.1761436238180425
Quick ratio: 1.1614170713007923
Effective tax rate (%): 0.18332605848974248
Interest coverage ratio: 19.07617504051864
COGS to revenue (%): 84.36966526156448
SG&A to revenue (%): 8.431718110349323
Free cash flow (dilution-adjusted): 3490000
Buyback yield (%): 0
Retained earnings: 322000
Inventory turnover: 331.2689804772234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.714693968511989
FCF margin (%): 1.9281022280906261
Revenue growth (%): 10.552803718339451
Rule of 40 score: 12.480905946430077
Financial ratios for GENK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.38
Shares outstanding: 5364808
Market cap (USD): 44957091.04000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENK — annual report dated 2024-12-31
Total revenue: 208380000
Gross profit: 29531000
Operating income: 8083000
Net income: 4532000
Capital expenditures: 23825000
Operating cash flow: 17827000
Depreciation & amortization: 13671000
Net tangible assets: 2093000
Owner earnings: -5622000
Return on net tangible assets (%): -268.60965121834687
Capex to operating income (%): 294.7544228627985
Buffett classification: The Gruesome
Stock price: 7.43
P/E ratio: 8.795349390997352
Shares outstanding: 5364808
Book value: 45617000
P/B ratio: 0.8738085240151697
Market cap (USD): 39860523.44
Debt to equity: 3.5734265734265733
Current ratio: 0.8252696681195062
Quick ratio: 0.8075677518322822
Effective tax rate (%): 7.302106770300674
Interest coverage ratio: 20.25814536340852
COGS to revenue (%): 85.8282944620405
SG&A to revenue (%): 10.234187541990595
Free cash flow (dilution-adjusted): -8984000
Buyback yield (%): 0
Retained earnings: 915000
Inventory turnover: 246.009628610729
Receivables turnover: 59.75910524806424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.054759062133176
FCF margin (%): -4.311354256646511
Revenue growth (%): 15.122619567199058
Rule of 40 score: 10.811265310552546
Financial ratios for GENK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.43
Shares outstanding: 5364808
Market cap (USD): 39860523.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENK — quarterly report dated 2025-03-31
Total revenue: 57337000
Gross profit: 6876000
Operating income: 472000
Net income: -301000
Capital expenditures: 6829000
Operating cash flow: 2154000
Depreciation & amortization: 3589000
Net tangible assets: 2873000
Owner earnings: -3541000
Return on net tangible assets (%): -123.25095718760876
Capex to operating income (%): 1446.822033898305
Buffett classification: The Gruesome
Stock price: 5.48
Shares outstanding: 5364808
Book value: 44292000
P/B ratio: 0.6637575146753364
Market cap (USD): 29399147.840000004
Debt to equity: 3.604872211686083
Current ratio: 0.6371919001513724
Quick ratio: 0.6116585268328907
Interest coverage ratio: 4.968421052631579
COGS to revenue (%): 88.00774369081047
SG&A to revenue (%): 11.109754608716885
Free cash flow (dilution-adjusted): -5409000
Buyback yield (%): 0
Retained earnings: 615000
Inventory turnover: 56.44407158836689
Receivables turnover: 47.113393590797045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.23916898910564988
FCF margin (%): -9.433699007621605
Rule of 40 score: -9.433699007621605
Financial ratios for GENK — quarterly report dated 2025-06-30
Total revenue: 55041000
Gross profit: 6610000
Operating income: 171000
Net income: -261000
Capital expenditures: 9638000
Operating cash flow: 3326000
Depreciation & amortization: 3930000
Net tangible assets: 3720000
Owner earnings: -5969000
Return on net tangible assets (%): -160.4569892473118
Capex to operating income (%): 5636.25730994152
Buffett classification: The Gruesome
Stock price: 3.9
Shares outstanding: 5364808
Book value: 42526000
P/B ratio: 0.49199904058693505
Market cap (USD): 20922751.2
Debt to equity: 4.093942529276207
Current ratio: 0.443585005279831
Quick ratio: 0.4198521647307286
Interest coverage ratio: 1.1793103448275861
COGS to revenue (%): 87.99077051652404
SG&A to revenue (%): 11.633146200105376
Free cash flow (dilution-adjusted): -7046000
Buyback yield (%): 0
Retained earnings: 354000
Inventory turnover: 53.872080088987765
Receivables turnover: 32.89958158995816
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.08203524157219821
FCF margin (%): -12.801366254246835
Revenue growth (%): -4.004395067757295
Rule of 40 score: -16.80576132200413
Financial ratios for GENK — quarterly report dated 2025-09-30
Total revenue: 50418000
Gross profit: 4612000
Operating income: -1895000
Net income: -566000
Capital expenditures: 6056000
Operating cash flow: -1640000
Depreciation & amortization: 4103000
Net tangible assets: 4246000
Owner earnings: -2519000
Return on net tangible assets (%): -59.32642487046632
Buffett classification: The Gruesome
Stock price: 2.75
Shares outstanding: 5364808
Book value: 39587000
P/B ratio: 0.3726784550483745
Market cap (USD): 14753222
Debt to equity: 4.434309242933286
Current ratio: 0.3261465510854264
Quick ratio: 0.3043145390333654
Interest coverage ratio: -9.570707070707071
COGS to revenue (%): 90.85247332301955
SG&A to revenue (%): 12.824784799079694
Free cash flow (dilution-adjusted): -8430000
Buyback yield (%): 0
Retained earnings: -212000
Inventory turnover: 51.81674208144796
Receivables turnover: 28.516968325791854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9241738519761227
FCF margin (%): -16.720218969415683
Revenue growth (%): -8.399193328609583
Rule of 40 score: -25.119412298025267
Financial ratios for GENK — annual report dated 2025-12-31
Total revenue: 212541000
Gross profit: 19473000
Operating income: -6620000
Net income: -3026000
Capital expenditures: 27734000
Operating cash flow: 3414000
Depreciation & amortization: 15515000
Net tangible assets: 4751000
Owner earnings: -15245000
Return on net tangible assets (%): -320.8798147758367
Buffett classification: The Gruesome
Stock price: 2.11
Shares outstanding: 5364808
Book value: 28006000
P/B ratio: 0.40418999071627504
Market cap (USD): 11319744.879999999
Debt to equity: 6.6848175390987645
Current ratio: 0.42064578170655026
Quick ratio: 0.3982320523726745
Interest coverage ratio: -8.275
COGS to revenue (%): 90.83800302059367
SG&A to revenue (%): 12.202351546289893
Free cash flow (dilution-adjusted): -27256000
Buyback yield (%): 0.7950709221284148
Retained earnings: -2111000
Inventory turnover: 159.2970297029703
Receivables turnover: 19.038068792547474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.216996627499004
FCF margin (%): -12.823878686935696
Revenue growth (%): 1.996832709473078
Rule of 40 score: -10.827045977462618
Financial ratios for GENK — quarterly report dated 2025-12-31
Total revenue: 49746000
Gross profit: 1375000
Operating income: -5368000
Net income: -1899000
Capital expenditures: 5211000
Operating cash flow: -426000
Depreciation & amortization: 3893000
Net tangible assets: 4751000
Owner earnings: -3217000
Return on net tangible assets (%): -67.71206061881709
Buffett classification: The Gruesome
Stock price: 2.11
Shares outstanding: 5364808
Book value: 28006000
P/B ratio: 0.40418999071627504
Market cap (USD): 11319744.879999999
Debt to equity: 6.6848175390987645
Current ratio: 0.42064578170655026
Quick ratio: 0.3982320523726745
Interest coverage ratio: -14.828729281767956
COGS to revenue (%): 97.23595867004381
SG&A to revenue (%): 13.460378723917502
Free cash flow (dilution-adjusted): -6371000
Buyback yield (%): 0
Retained earnings: -2111000
Inventory turnover: 39.91006600660066
Receivables turnover: 4.455929774274454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.608585784956896
FCF margin (%): -12.807059864109677
Revenue growth (%): -1.3328573128644532
Rule of 40 score: -14.13991717697413
Financial ratios for GLEN.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.04054054054054054
Shares outstanding: 11718025332
Market cap (USD): 475055081.0270271
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLEN.L — annual report dated 2022-12-31
Total revenue: 278243478260.86957
Gross profit: 29909782608.695652
Operating income: 26990217391.304348
Net income: 18826086956.52174
Capital expenditures: 4471739130.434782
Operating cash flow: 14846739130.434782
Depreciation & amortization: 7594565217.391304
Net tangible assets: 46847826086.95652
Owner earnings: 21948913043.478264
Return on net tangible assets (%): 46.85150812064966
Capex to operating income (%): 16.567999677822076
Buffett classification: The Great
Stock price: 0.05686746987951807
P/E ratio: 0.035396333510724284
Shares outstanding: 11718025332
Book value: 49151086956.52174
P/B ratio: 0.013557674791696955
Market cap (USD): 666374452.6149398
Debt to equity: 0.6363917822154403
Current ratio: 1.2958255335080495
Quick ratio: 0.6694683639086485
Effective tax rate (%): 27.833384326238036
Interest coverage ratio: 14.020892151326935
COGS to revenue (%): 89.25050003125195
SG&A to revenue (%): 0.9492780798799925
Free cash flow (dilution-adjusted): 9073913043.47826
Buyback yield (%): 408.27678240617587
Retained earnings: 27441304347.826084
Inventory turnover: 6.828063359234907
Receivables turnover: 20.27114349065569
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.36692646817326
FCF margin (%): 3.2611413213325826
Rule of 40 score: 3.2611413213325826
Financial ratios for GLEN.L — annual report dated 2023-12-31
Total revenue: 259320238095.2381
Gross profit: 12836904761.904762
Operating income: 10355952380.952381
Net income: 5095238095.238095
Capital expenditures: 5163095238.095239
Operating cash flow: 13138095238.095238
Depreciation & amortization: 7120238095.238095
Net tangible assets: 44557142857.14286
Owner earnings: 7052380952.380952
Return on net tangible assets (%): 15.827722560649779
Capex to operating income (%): 49.85630532245086
Buffett classification: The Good
Stock price: 0.0560759493670886
P/E ratio: 0.12896343270270436
Shares outstanding: 11718025332
Book value: 45520238095.2381
P/B ratio: 0.014435324213917793
Market cap (USD): 657099395.1994936
Debt to equity: 0.8431885346653765
Current ratio: 1.2943530457981327
Quick ratio: 0.6563118961962893
Effective tax rate (%): 40.74210817795828
Interest coverage ratio: 3.458846918489065
COGS to revenue (%): 95.04978675933874
SG&A to revenue (%): 0.9663543421674801
Free cash flow (dilution-adjusted): 6916666666.666667
Buyback yield (%): 665.2613901891383
Retained earnings: 35246428571.42857
Inventory turnover: 6.558522601286072
Receivables turnover: 20.725880114176974
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.693618851742817
FCF margin (%): 2.667229799521643
Revenue growth (%): -6.8009644948047345
Rule of 40 score: -4.133734695283092
Financial ratios for GLEN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 38434444444.44444
Buffett classification: The Gruesome
Stock price: 0.0425
Shares outstanding: 11718025332
Book value: 39622222222.22221
P/B ratio: 0.012569110178042629
Market cap (USD): 498016076.61
Debt to equity: 1.0686203028603478
Current ratio: 1.1972479832625882
Quick ratio: 0.6021847150415418
Buyback yield (%): 0
Retained earnings: 30154444444.444443
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLEN.L — annual report dated 2024-12-31
Total revenue: 256604444444.44443
Gross profit: 7388888888.888888
Operating income: 4934444444.444445
Net income: -1815555555.5555556
Capital expenditures: 6075555555.555555
Operating cash flow: 11172222222.222221
Depreciation & amortization: 7331111111.111111
Net tangible assets: 38434444444.44444
Owner earnings: -560000000
Return on net tangible assets (%): -1.4570263941487671
Capex to operating income (%): 123.1254222022067
Buffett classification: The Gruesome
Stock price: 0.0425
Shares outstanding: 11718025332
Book value: 39622222222.22221
P/B ratio: 0.012569110178042629
Market cap (USD): 498016076.61
Debt to equity: 1.0686203028603478
Current ratio: 1.1972479832625882
Quick ratio: 0.6021847150415418
Interest coverage ratio: 1.5203697363916469
COGS to revenue (%): 97.12051406401552
SG&A to revenue (%): 0.8759699321047526
Free cash flow (dilution-adjusted): 4311111111.111111
Buyback yield (%): 51.31472005785929
Retained earnings: 30154444444.444443
Inventory turnover: 7.58262339418526
Receivables turnover: 21.23037323037323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.499622295699126
FCF margin (%): 1.68006096716087
Revenue growth (%): -1.047274085023887
Rule of 40 score: 0.6327868821369829
Financial ratios for GLEN.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 39718750000
Buffett classification: The Gruesome
Stock price: 0.03794520547945206
Shares outstanding: 11718025332
Book value: 40985000000
P/B ratio: 0.010848917385291312
Market cap (USD): 444642879.0361644
Debt to equity: 1.2724777357569843
Current ratio: 1.147944632467582
Quick ratio: 0.581035859603757
Buyback yield (%): 0
Retained earnings: 32886250000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GOKEX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.324673612026902
Shares outstanding: 73273628
Market cap (USD): 390158153.4690755
Buyback yield (%): 0
Retained earnings: 5049571.409732296
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GOKEX.NS — annual report dated 2023-03-31
Total revenue: 251651827.0401949
Gross profit: 104292375.15225336
Operating income: 23659549.330085263
Net income: 21067771.010962244
Capital expenditures: 15400669.914738126
Operating cash flow: 44923629.71985384
Depreciation & amortization: 8739378.80633374
Net tangible assets: 107811412.91108406
Owner earnings: 14406479.902557857
Return on net tangible assets (%): 13.362666821219937
Capex to operating income (%): 65.09282869202744
Buffett classification: The Good
Stock price: 4.330450669914738
P/E ratio: 15.061291073202655
Shares outstanding: 73273628
Book value: 107947771.01096225
P/B ratio: 2.939457003030292
Market cap (USD): 317307831.4596833
Debt to equity: 0.17422983461122535
Current ratio: 2.543603994769319
Quick ratio: 1.696517572596227
Effective tax rate (%): 15.374167765874585
Interest coverage ratio: 11.430541089240004
COGS to revenue (%): 58.556877421122266
SG&A to revenue (%): 1.9444000093898466
Free cash flow (dilution-adjusted): 25629549.330085263
Buyback yield (%): 0
Inventory turnover: 4.129192176447018
Receivables turnover: 15.211000332776742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.499896098211785
FCF margin (%): 10.18452742089236
Rule of 40 score: 10.18452742089236
Financial ratios for GOKEX.NS — annual report dated 2024-03-31
Total revenue: 262950437.7023624
Gross profit: 122536683.05552225
Operating income: 19645712.915217653
Net income: 15705959.94723588
Capital expenditures: 82500383.73905744
Operating cash flow: -21232965.583403286
Depreciation & amortization: 10645688.931526562
Net tangible assets: 84461326.29811728
Owner earnings: -56148734.860295
Return on net tangible assets (%): -66.4786326727936
Capex to operating income (%): 419.9409005674326
Buffett classification: The Gruesome
Stock price: 8.468090211132438
P/E ratio: 39.506511800965114
Shares outstanding: 73273628
Book value: 154855498.2611824
P/B ratio: 4.006881892914339
Market cap (USD): 620487692.0009598
Debt to equity: 0.6232747378691902
Current ratio: 1.3683907973379827
Quick ratio: 0.772715035564747
Effective tax rate (%): 17.624668069652852
Interest coverage ratio: 6.205280103026401
COGS to revenue (%): 53.39932341385818
SG&A to revenue (%): 2.8890334971661304
Free cash flow (dilution-adjusted): -106764959.82731743
Buyback yield (%): 0
Retained earnings: 40133553.18383499
Inventory turnover: 1.9398705074516782
Receivables turnover: 6.220110125554252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.48167917101634
FCF margin (%): -40.60269332891026
Revenue growth (%): 4.4897789120214995
Rule of 40 score: -36.11291441688876
Financial ratios for GOKEX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 162815946.01051122
Buffett classification: The Gruesome
Stock price: 11.589225991399905
Shares outstanding: 73273628
Book value: 232695699.95222172
P/B ratio: 3.649335309058684
Market cap (USD): 849184634.1017679
Debt to equity: 0.29592274307997357
Current ratio: 2.1041779650903436
Quick ratio: 1.2924858914623802
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0